Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A Recent Study Indicated That Patients with Severe Dementia Required an Additional 41+ Hours of Care Per Week.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c37810) has announced the addition of "Severe Dementia" to their offering.

Severe dementia has not had a high profile in the clinical literature as until recently prognosis was poor and there were few beneficial interventions. With the recent licensing of memantine, clinicians finally have a drug option that will effect disease progression. Dementia brings a huge burden of care and is expensive in health economics terms, and severe dementia is even costlier due to higher rates of institutionalization Institutionalization

The gradual domination of financial markets by institutional investors, as opposed to individual investors. This process has occurred throughout the industrialized world.
.

A recent study indicated that patients with severe dementia required an additional 41+ hours of care per week. Now that more can be done at this stage of the disease to lessen or manage its effects, clinical interest has increased and a text on clinical management is needed by psychiatric and geriatric medicine practitioners.

Introductory chapters on the Differential Diagnosis differential diagnosis
n.
Determination of which one of two or more diseases with similar symptoms is the one from which the patient is suffering. Also called differentiation.
, Neurochemistry neurochemistry /neu·ro·chem·is·try/ (-kem´is-tre) the branch of neurology dealing with the chemistry of the nervous system.

neu·ro·chem·is·try
n.
 and Molecular Pathology Molecular pathology is an emerging discipline within pathology which is focused on the use of nucleic acid-based techniques such as DNA sequencing, fluorescent in-situ hybridization, reverse-transcriptase polymerase chain reaction, and nucleic acid microarrays for specialised studies of  of severe dementia set the scene for the clinical discussion. These are followed by detailed clinical chapters on Cognitive Function cognitive function Neurology Any mental process that involves symbolic operations–eg, perception, memory, creation of imagery, and thinking; CFs encompasses awareness and capacity for judgment , Depression, Physical Effects Physical effects is the term given to a sub-category of special effects in which mechanical or physical effects are recorded. Physical effects are usually planned in preproduction and created in production. , Staging and Function. All therapeutic interventions are then discussed, including chapters dedicated to Memantine, Anticholinesterases, Neuroleptics Neuroleptics
Any of a class of drugs used to treat psychotic conditions.

Mentioned in: Stuttering, Tardive Dyskinesia
 and Nonpharmacological treatment. The final chapters review the social and economic aspects of dementia care, including family involvement, person-centered care, palliative care palliative care (paˑ·lē·ā·tiv kerˑ),
n an approach to health care that is concerned primarily with attending to physical and emotional comfort rather
, ethics and health economics. "Severe Dementia" summarises current knowledge of pathophysiology pathophysiology /patho·phys·i·ol·o·gy/ (-fiz?e-ol´ah-je) the physiology of disordered function.

path·o·phys·i·ol·o·gy
n.
1.
 and provides a detailed guide to all aspects of the clinical management of these patients.

Key topics covered:

Part 1: Introductory

--Assessment and Diagnosis of Severe Dementia

--Neurochemistry of Severe Dementia

--The Molecular Pathology of Severe Dementia

Part 2: Clinical Features of Severe Dementia

--Cognitive Functions in Severe Dementia

--Behavioural and Psychological Symptons of Dementia Agitation

--Depression in Severe Dementia

--Physical Aspects of Severe Alzheimers Disease

--Clinical Features of Severe Dementia: Staging

--Clinical Features of Severe Dementia: Function

Part 3: Management

--Drug Treatment: Memantine

--Drug Treatment: Cholinesterase Inhibitors

--Drug Treatment: Treatment of Behavioural and Psychological Symptoms of Dementia with Neuroleptics

--Non-pharmacological Treatment Severe Dementia: An Overview

--Non-pharmacological Treatment of Severe Dementia: the Seattle Protocols

--Care by Families for Late Stage Dementia

--Person-centred Care for People with Severe Dementia

--Palliative Care in Patients with Severe Dementia.

--Narrative Ethics and Ethical Narratives in Dementia

--Health Economics of Severe Dementia

For more information visit http://www.researchandmarkets.com/reports/c37810
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 30, 2006
Words:381
Previous Article:UnderSea Resort to Participate in Sustainable Design Competition for New Orleans Chair by Brad Pitt.
Next Article:Columbia College Opts for Jenzabar's Total Campus Management; ERP, Web Portal and LMS Solutions Will Replace Existing Systems.
Topics:



Related Articles
Managing the sundowning patient.
Canadian Consensus Conference on Dementia, February 27-28, 1998: Conference Highlights [*].
Coding and Reimbursement for Dementia.
Team C: medicine, geriatric medicine, medical management & administration, and ophthalmology.
Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia. (Case Report).
Members urged to support sale staffing standards.
Hearing loss as the initial presentation of Creutzfeldt-Jakob disease.
Walking away from dementia: moderate exercise protects aging minds.
Treatments for Alzheimer disease.
Complementary and integrative approaches to dementia.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles